D-Amphetamine Sulfate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

35 Suppliers, 26 USDMF, 3 CEP/COS, 16 NDC API, 13 Listed Suppliers

DEVELOPMENTS

24 Drug(s) in Development

24 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

3 Suppliers

3 Suppliers

DOSSIERs // Finished Dosage Forms

450 Dossiers, 423 FDA Orange Book, 6 Europe, 6 Canada, 1 Australia, 2 South Africa, 12 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, EXTENDED RELEASE;ORAL - 10MG, CAPSULE, EXTENDED RELEASE;ORAL - 15MG, CAPSULE, EXTENDED RELEASE;ORAL - 5MG, SUSPENSION, EXTENDED RELEASE;ORAL - EQ 1.25MG BASE/ML, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 15.7MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 18.8MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 3.1MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 6.3MG BASE, TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 9.4MG BASE, CAPSULE, EXTENDED RELEASE;ORAL - 1.25MG;1.25MG;1.25MG;1.25MG, CAPSULE, EXTENDED RELEASE;ORAL - 2.5MG;2.5MG;2.5MG;2.5MG, CAPSULE, EXTENDED RELEASE;ORAL - 3.75MG;3.75MG;3.75MG;3.75MG, CAPSULE, EXTENDED RELEASE;ORAL - 5MG;5MG;5MG;5MG, CAPSULE, EXTENDED RELEASE;ORAL - 6.25MG;6.25MG;6.25MG;6.25MG, CAPSULE, EXTENDED RELEASE;ORAL - 7.5MG;7.5MG;7.5MG;7.5MG

RELATED EXCIPIENT COMPANIES

Suppliers, 35 BASF, 33 Roquette, 31 Kerry, 21 Corel Pharma Chem, 18 SPI Pharma, 16 Microlex e.U, 14 Seppic, 13 Ideal Cures Pvt Ltd, 12 Gangwal Healthcare, 12 Gangwal Chemicals, 11 Sigachi Industries, 10 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 7 Rochem International Inc, 6 Lonza Capsugel, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 5 Nanjing Well Pharmaceutical, 5 DFE Pharma, 4 Evonik, 4 Ingredion Pharma Solutions, 4 ACG Worldwide, 4 Pharmatrans-Sanaq, 3 Prachin Chemical, 3 Kima Chemical, 3 Vasa Pharmachem, 3 Doshion Polyscience, 3 Shijiazhuang Huaxu Pharmaceutical, 2 Pharm-RX Chemical, 2 Alcedo Pharmachem, 2 Pfanstiehl, 2 Nomisma Healthcare, 2 Ulanqab Kema New Material, 2 Seqens, 2 Finar, 2 The Dow Chemical Company, 2 Qualicaps, 1 Nanjing Bold Chemical, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical, 1 Jai Radhe Sales, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 Bioplus Life Sciences

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 67 Coating Systems & Additives, 49 Controlled & Modified Release, 45 Direct Compression, 35 Taste Masking, 33 Disintegrants & Superdisintegrants, 33 Solubilizers, 29 Granulation, 28 Thickeners and Stabilizers, 21 Film Formers & Plasticizers, 19 Parenteral, 19 Chewable & Orodispersible Aids, 18 Lubricants & Glidants, 15 Co-Processed Excipients, 15 Topical, 9 Empty Capsules, 8 API Stability Enhancers, 7 Emulsifying Agents, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 3 Rheology Modifiers, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

91 US Medicaid Prescriptions, 17 Finished Drug Prices

MARKET PLACE

9 APIs

9 APIs

PATENTS

101 US Patents, 4 US Exclusivities

ANALYTICAL SOLUTION(s)

5 USP Standards, 8 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 102 News

Information, Expiry, & Status of FDA Orange Book Exclusivities covering D-Amphetamine Sulfate

D-Amphetamine Sulfate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

35 Suppliers

26 USDMF

3 CEP/COS

16 NDC API

13 Listed Suppliers

DEVELOPMENTS

24 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

3 Suppliers

DOSSIERs // Finished Dosage Forms

450 Dossiers

423 FDA Orange Book

6 Europe

6 Canada

1 Australia

2 South Africa

12 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE, EXTENDED RELEASE;ORAL - 10MG

CAPSULE, EXTENDED RELEASE;ORAL - 15MG

CAPSULE, EXTENDED RELEASE;ORAL - 5MG

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 1.25MG BASE/ML

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 12.5MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 15.7MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 18.8MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 3.1MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 6.3MG BASE

TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL - EQ 9.4MG BASE

CAPSULE, EXTENDED RELEASE;ORAL - 1.25MG;1.25MG;1.25MG;1.25MG

CAPSULE, EXTENDED RELEASE;ORAL - 2.5MG;2.5MG;2.5MG;2.5MG

CAPSULE, EXTENDED RELEASE;ORAL - 3.75MG;3.75MG;3.75MG;3.75MG

CAPSULE, EXTENDED RELEASE;ORAL - 5MG;5MG;5MG;5MG

CAPSULE, EXTENDED RELEASE;ORAL - 6.25MG;6.25MG;6.25MG;6.25MG

CAPSULE, EXTENDED RELEASE;ORAL - 7.5MG;7.5MG;7.5MG;7.5MG

RELATED EXCIPIENT COMPANIES

Suppliers

35 BASF

33 Roquette

31 Kerry

21 Corel Pharma Chem

18 SPI Pharma

16 Microlex e.U

14 Seppic

13 Ideal Cures Pvt Ltd

12 Gangwal Healthcare

12 Gangwal Chemicals

11 Sigachi Industries

10 Actylis

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Rochem International Inc

6 Lonza Capsugel

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 DKSH

5 Boai NKY Pharmaceuticals Ltd

5 Nanjing Well Pharmaceutical

5 DFE Pharma

4 Evonik

4 Ingredion Pharma Solutions

4 ACG Worldwide

4 Pharmatrans-Sanaq

3 Prachin Chemical

3 Kima Chemical

3 Vasa Pharmachem

3 Doshion Polyscience

3 Shijiazhuang Huaxu Pharmaceutical

2 Pharm-RX Chemical

2 Alcedo Pharmachem

2 Pfanstiehl

2 Nomisma Healthcare

2 Ulanqab Kema New Material

2 Seqens